4.7 Editorial Material

Optimal antiplatelet therapy in patients at high bleeding risk undergoing complex percutaneous coronary intervention

Journal

EUROPEAN HEART JOURNAL
Volume 43, Issue 33, Pages 3115-3117

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/eurheartj/ehac369

Keywords

-

Ask authors/readers for more resources

This editorial discusses a study on the duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk.
This editorial refers to 'Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis', by M. Valgimigli et al., https://doi.org/10.1093/eurheartj/ehac284.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available